ArticleHuman vaccines & immunotherapeutics2026
T cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2.
Fábio Mambelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.